Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifeward Ltd. - Ordinary Shares (NQ: LFWD )

1.480 -0.140 (-8.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lifeward Ltd. - Ordinary Shares

< Previous 1 2 Next >
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
With recent financing and current capital, the Company believes it has sufficient cash to pursue its goals 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders
From Lifeward Ltd.
Via GlobeNewswire
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors
Financial executive brings over 30 years of experience and leadership in financial management and strategy 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Report Third Quarter Financial Results on November 12, 2024
From Lifeward, Ltd.
Via GlobeNewswire
Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies
From Lifeward, Inc.
Via GlobeNewswire
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
From Lifeward, Inc.
Via GlobeNewswire
Lifeward Launches Direct Sales of AlterG Product Line in Germany
Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward’s path to profitability 
From Lifeward, Inc.
Via GlobeNewswire
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician,... 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Reports Second Quarter 2024 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Report Second Quarter Financial Results on August 15, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Lifeward to Present at Sidoti Virtual Investor Conference on June 12
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Reports First Quarter 2024 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Report First Quarter Financial Results on May 15, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces Reverse Share Split
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.